vs
Acadia Healthcare Company, Inc.（ACHC）与Martin Marietta Materials（MLM）财务数据对比。点击上方公司名可切换其他公司
Martin Marietta Materials的季度营收约是Acadia Healthcare Company, Inc.的1.4倍（$1.1B vs $821.5M），Martin Marietta Materials净利率更高（24.5% vs -143.3%，领先167.8%），Acadia Healthcare Company, Inc.同比增速更快（6.1% vs -30.1%），Martin Marietta Materials自由现金流更多（$424.0M vs $-179.5M），过去两年Acadia Healthcare Company, Inc.的营收复合增速更高（3.4% vs -4.5%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
马丁·玛丽埃塔材料公司是美国大型集料及重型建筑材料供应商，业务覆盖美国26个州、加拿大及加勒比地区，主要为道路、人行道、地基等各类基建项目提供所需原材料。
ACHC vs MLM — 直观对比
营收规模更大
MLM
是对方的1.4倍
$821.5M
营收增速更快
ACHC
高出36.2%
-30.1%
净利率更高
MLM
高出167.8%
-143.3%
自由现金流更多
MLM
多$603.5M
$-179.5M
两年增速更快
ACHC
近两年复合增速
-4.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $821.5M | $1.1B |
| 净利润 | $-1.2B | $279.0M |
| 毛利率 | — | 35.0% |
| 营业利润率 | -142.4% | 24.6% |
| 净利率 | -143.3% | 24.5% |
| 营收同比 | 6.1% | -30.1% |
| 净利润同比 | -3710.4% | -4.8% |
| 每股收益（稀释后） | $-12.98 | $4.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCMLM
| Q4 25 | $821.5M | $1.1B | ||
| Q3 25 | $851.6M | $1.8B | ||
| Q2 25 | $869.2M | $1.8B | ||
| Q1 25 | $770.5M | $1.4B | ||
| Q4 24 | $774.2M | $1.6B | ||
| Q3 24 | $815.6M | $1.9B | ||
| Q2 24 | $796.0M | $1.8B | ||
| Q1 24 | $768.1M | $1.3B |
净利润ACHCMLM
| Q4 25 | $-1.2B | $279.0M | ||
| Q3 25 | $36.2M | $414.0M | ||
| Q2 25 | $30.1M | $328.0M | ||
| Q1 25 | $8.4M | $116.0M | ||
| Q4 24 | $32.6M | $293.0M | ||
| Q3 24 | $68.1M | $363.0M | ||
| Q2 24 | $78.5M | $294.0M | ||
| Q1 24 | $76.4M | $1.0B |
毛利率ACHCMLM
| Q4 25 | — | 35.0% | ||
| Q3 25 | — | 33.1% | ||
| Q2 25 | — | 30.0% | ||
| Q1 25 | — | 24.8% | ||
| Q4 24 | — | 30.0% | ||
| Q3 24 | — | 31.7% | ||
| Q2 24 | — | 29.3% | ||
| Q1 24 | — | 21.7% |
营业利润率ACHCMLM
| Q4 25 | -142.4% | 24.6% | ||
| Q3 25 | 4.7% | 27.4% | ||
| Q2 25 | 5.8% | 25.3% | ||
| Q1 25 | 1.7% | 14.3% | ||
| Q4 24 | 4.9% | 24.4% | ||
| Q3 24 | 12.1% | 25.9% | ||
| Q2 24 | 13.4% | 22.6% | ||
| Q1 24 | 12.9% | — |
净利率ACHCMLM
| Q4 25 | -143.3% | 24.5% | ||
| Q3 25 | 4.3% | 22.4% | ||
| Q2 25 | 3.5% | 18.1% | ||
| Q1 25 | 1.1% | 8.6% | ||
| Q4 24 | 4.2% | 18.0% | ||
| Q3 24 | 8.4% | 19.2% | ||
| Q2 24 | 9.9% | 16.7% | ||
| Q1 24 | 9.9% | 83.5% |
每股收益（稀释后）ACHCMLM
| Q4 25 | $-12.98 | $4.59 | ||
| Q3 25 | $0.40 | $6.85 | ||
| Q2 25 | $0.33 | $5.43 | ||
| Q1 25 | $0.09 | $1.90 | ||
| Q4 24 | $0.36 | $4.87 | ||
| Q3 24 | $0.74 | $5.91 | ||
| Q2 24 | $0.85 | $4.76 | ||
| Q1 24 | $0.83 | $16.87 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $133.2M | $67.0M |
| 总债务越低越好 | $2.5B | $5.3B |
| 股东权益账面价值 | $1.9B | $10.0B |
| 总资产 | $5.5B | $18.7B |
| 负债/权益比越低杠杆越低 | 1.28× | 0.53× |
8季度趋势，按日历期对齐
现金及短期投资ACHCMLM
| Q4 25 | $133.2M | $67.0M | ||
| Q3 25 | $118.7M | $57.0M | ||
| Q2 25 | $131.4M | $225.0M | ||
| Q1 25 | $91.2M | $101.0M | ||
| Q4 24 | $76.3M | $670.0M | ||
| Q3 24 | $82.1M | $52.0M | ||
| Q2 24 | $77.2M | $109.0M | ||
| Q1 24 | $77.3M | $2.6B |
总债务ACHCMLM
| Q4 25 | $2.5B | $5.3B | ||
| Q3 25 | $2.3B | $5.5B | ||
| Q2 25 | $2.3B | $5.4B | ||
| Q1 25 | $2.2B | $5.4B | ||
| Q4 24 | $2.0B | $5.4B | ||
| Q3 24 | $1.9B | $4.0B | ||
| Q2 24 | $1.8B | $4.3B | ||
| Q1 24 | $1.9B | $4.3B |
股东权益ACHCMLM
| Q4 25 | $1.9B | $10.0B | ||
| Q3 25 | $3.1B | $9.7B | ||
| Q2 25 | $3.1B | $9.4B | ||
| Q1 25 | $3.0B | $9.1B | ||
| Q4 24 | $3.1B | $9.5B | ||
| Q3 24 | $3.0B | $9.2B | ||
| Q2 24 | $3.0B | $8.8B | ||
| Q1 24 | $2.9B | $8.9B |
总资产ACHCMLM
| Q4 25 | $5.5B | $18.7B | ||
| Q3 25 | $6.4B | $18.7B | ||
| Q2 25 | $6.3B | $18.1B | ||
| Q1 25 | $6.1B | $17.7B | ||
| Q4 24 | $6.0B | $18.2B | ||
| Q3 24 | $5.9B | $16.5B | ||
| Q2 24 | $5.7B | $16.3B | ||
| Q1 24 | $5.5B | $16.2B |
负债/权益比ACHCMLM
| Q4 25 | 1.28× | 0.53× | ||
| Q3 25 | 0.74× | 0.57× | ||
| Q2 25 | 0.74× | 0.58× | ||
| Q1 25 | 0.72× | 0.60× | ||
| Q4 24 | 0.64× | 0.57× | ||
| Q3 24 | 0.62× | 0.44× | ||
| Q2 24 | 0.62× | 0.49× | ||
| Q1 24 | 0.65× | 0.49× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-86.3M | $629.0M |
| 自由现金流经营现金流 - 资本支出 | $-179.5M | $424.0M |
| 自由现金流率自由现金流/营收 | -21.8% | 37.2% |
| 资本支出强度资本支出/营收 | 11.3% | 18.0% |
| 现金转化率经营现金流/净利润 | — | 2.25× |
| 过去12个月自由现金流最近4个季度 | $-439.9M | $978.0M |
8季度趋势，按日历期对齐
经营现金流ACHCMLM
| Q4 25 | $-86.3M | $629.0M | ||
| Q3 25 | $73.2M | $551.0M | ||
| Q2 25 | $133.5M | $387.0M | ||
| Q1 25 | $11.5M | $218.0M | ||
| Q4 24 | $116.7M | $686.0M | ||
| Q3 24 | $163.1M | $600.0M | ||
| Q2 24 | $171.1M | $1.0M | ||
| Q1 24 | $-321.3M | $172.0M |
自由现金流ACHCMLM
| Q4 25 | $-179.5M | $424.0M | ||
| Q3 25 | $-63.0M | $361.0M | ||
| Q2 25 | $-34.2M | $208.0M | ||
| Q1 25 | $-163.2M | $-15.0M | ||
| Q4 24 | $-86.8M | $453.0M | ||
| Q3 24 | $-27.1M | $317.0M | ||
| Q2 24 | $16.9M | $-138.0M | ||
| Q1 24 | $-463.7M | $-28.0M |
自由现金流率ACHCMLM
| Q4 25 | -21.8% | 37.2% | ||
| Q3 25 | -7.4% | 19.6% | ||
| Q2 25 | -3.9% | 11.5% | ||
| Q1 25 | -21.2% | -1.1% | ||
| Q4 24 | -11.2% | 27.8% | ||
| Q3 24 | -3.3% | 16.8% | ||
| Q2 24 | 2.1% | -7.8% | ||
| Q1 24 | -60.4% | -2.2% |
资本支出强度ACHCMLM
| Q4 25 | 11.3% | 18.0% | ||
| Q3 25 | 16.0% | 10.3% | ||
| Q2 25 | 19.3% | 9.9% | ||
| Q1 25 | 22.7% | 17.2% | ||
| Q4 24 | 26.3% | 14.3% | ||
| Q3 24 | 23.3% | 15.0% | ||
| Q2 24 | 19.4% | 7.9% | ||
| Q1 24 | 18.5% | 16.0% |
现金转化率ACHCMLM
| Q4 25 | — | 2.25× | ||
| Q3 25 | 2.02× | 1.33× | ||
| Q2 25 | 4.43× | 1.18× | ||
| Q1 25 | 1.37× | 1.88× | ||
| Q4 24 | 3.58× | 2.34× | ||
| Q3 24 | 2.39× | 1.65× | ||
| Q2 24 | 2.18× | 0.00× | ||
| Q1 24 | -4.21× | 0.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $451.2M | 55% |
| Comprehensive Treatment Centers | $144.2M | 18% |
| Medicare | $113.7M | 14% |
| Residential Treatment Centers | $89.7M | 11% |
| Self Payor | $16.1M | 2% |
| Other Payor | $10.7M | 1% |
MLM
| Building Materials Business East Group | $774.0M | 68% |
| Building Materials Business West Group | $233.0M | 20% |
| Services | $88.0M | 8% |
| Other | $45.0M | 4% |
